Ad is loading...
FTADX
Price
$48.40
Change
-$0.64 (-1.31%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

FTADX vs RERAX

Header iconFTADX vs RERAX Comparison
Open Charts FTADX vs RERAXBanner chart's image
Fidelity Advisor International Discv M
Price$48.40
Change-$0.64 (-1.31%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
FTADX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTADX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTADX is a Buy and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. FTADX (9.89B). FTADX pays higher dividends than RERAX: FTADX (1.23) vs RERAX (0.91). FTADX was incepted earlier than RERAX: FTADX (20 years) vs RERAX (22 years). FTADX is a more actively managed with annual turnover of: 49.00 vs. RERAX (34.00). FTADX has a lower initial minimum investment than RERAX: FTADX (0) vs RERAX (250). FTADX annual gain was more profitable for investors over the last year : 18.95 vs. RERAX (7.63). FTADX return over 5 years is better than : 14.88 vs. RERAX (3.85).
FTADXRERAXFTADX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years22 years-
Gain YTD10.7813.052353%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.89B129B8%
Annual Yield % from dividends1.230.91135%
Returns for 1 year18.957.63248%
Returns for 3 years-15.75-19.4581%
Returns for 5 years14.883.85386%
Returns for 10 years30.1315.89190%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics